Litigation Details for In Re: Zetia (Ezetimibe) Antitrust Litigation (E.D. Va. 2018)
✉ Email this page to a colleague
In Re: Zetia (Ezetimibe) Antitrust Litigation (E.D. Va. 2018)
| Docket | ⤷ Try a Trial | Date Filed | 2018-06-15 |
| Court | District Court, E.D. Virginia | Date Terminated | |
| Cause | 15:1 Antitrust Litigation | Assigned To | Rebecca Beach Smith |
| Jury Demand | Plaintiff | Referred To | Douglas E. Miller |
| Parties | ALBERTSONS COMPANIES, INC.; ALL END PAYER PLAINTIFFS; APOTEX USA, INC. AND APOTEX CORP.; CESAR CASTILLO, INC., INDIVIDUALLY AND ON BEHALF OF ALL THOSE SIMILARLY SITUATED; CITY OF PROVIDENCE, RHODE ISLAND ON ITS OWN BEHALF AND ON BEHALF OF ALL OTHERS SIMILARLY SITUATED; CVS PHARMACY, INC.; FRATERNAL ORDER OF POLICE, MIAMI LODGE 20, INSURANCE TRUST FUND ON BEHALF OF ITSELF AND ALL OTHERS SIMILARLY SITUATED; FWK HOLDINGS, LLC; GLENMARK GENERICS INC., USA; GLENMARK PHARMACEUTICALS, LTD.; HEB GROCERY COMPANY L.P.; IN RE: ZETIA (EZETIMIBE) ANTITRUST LITIGATION; INTERNATIONAL UNION OF OPERATING ENGINEERS LOCAL 49 HEALTH AND WELFARE FUND ON BEHALF OF ITSELF AND ALL OTHERS SIMILARLY; LAW ENFORCEMENT HEALTH BENEFITS INC.; MERCK & CO., INC.; MERCK SHARP & DOHME CORP.; MSP SINGAPORE CO. LLC; PAINTERS DISTRICT COUNCIL NO. 30 HEALTH AND WELFARE FUND, ON BEHALF OF ITSELF AND ALL OTHERS SIMILARLY SITUATED; PAR PHARMACEUTICAL, INC.; PHILADELPHIA FEDERATION OF TEACHERS HEALTH AND WELFARE FUND; RITE AID CORPORATION; RITE AID HDQTRS. CORP.; ROCHESTER DRUG COOPERATIVE, INC., ON BEHALF OF ITSELF AND ALL OTHERS SIMILARLY SITUATED; SCHERING CORP.; SCHERING-PLOUGH CORP.; SELF INSURED SCHOOLS OF CALIFORNIA ON BEHALF OF ITSELF AND ALL OTHERS SIMILARLY SITUATED; SERGEANTS BENEVOLENT ASSOCIATION HEALTH & WELFARE FUND, ON BEHALF OF ITSELF AND ALL OTHERS SIMILARLY SITUATED; ST. PAUL ELECTRICAL WORKERS' HEALTH PLAN, INDIVIDUALLY AND ON BEHALF OF ALL THOSE SIMILARLY SITUATED; THE KROGER CO.; THE RETIRED FIREFIGHTERS' SECURITY BENEFIT FUND OF THE UNIFORMED FIREFIGHTERS' ASSOCIATION; THE UNIFORMED FIREFIGHTERS' ASSOCIATION OF GREATER NEW YORK SECURITY BENEFIT FUND; TURLOCK IRRIGATION DISTRICT, INDIVIDUALLY AND ON BEHALF OF ALL THOSE SIMILARLY SITUATED; UFCW LOCAL 1500 WELFARE FUND, ON BEHALF OF ITSELF AND ALL OTHERS SIMILARLY SITUATED; WALGREEN CO.; WILSON SONSINI GOODRICH & ROSATI, P.C.; WISCONSIN MASONS' HEALTH CARE FUND, ON BEHALF OF ITSELF AND ALL OTHERS SIMILARLY SITUATED; ZYDUS PHARMACEUTICALS (USA) INC. | ||
| Patents | 10,029,015; 7,030,106; 7,612,058; RE37,336; RE37,343; RE37,721; RE42,208; RE42,353; RE42,461 | ||
| Attorneys | Adam Eric Polk; Adam Michael Carroll; Adam William Burrowbridge; Alan Brody Rashkind; Alberto Rodriguez; Alexander John Egervary; Amanda Lee Czocher; Anna Marie Horning Nygren; Anna Theresa Neill; Archana Tamoshunas; Ashley Elizabeth Johnson; Ashley Marie Bond; Barry Lee Refsin; Barry Steven Taus; Benjamin Mordecai Greenblum; Bradley Joseph Demuth; Bradley Joseph Vettraino; Brian Brooks; Brian Murray; Brian Sodikoff; Caeli Anne Higney; Christina Hildegard Connolly Sharp; Christine A. Williams; Christopher Dean Dusseault; Christopher Van Le; Conrad Moss Shumadine; Craig Crandall Reilly; David Alan Forkner; David Francis Sorensen; David Neil Ventker; David Paul Germaine; Deborah Lynn Stein; Debra Josephson; Devona Lynn Wells; Donald Charles Schultz; Donald Sean Nation; Dustin Mitchell Paul; Ellen Toporoff Noteware; Eric Grannon; Eric Jonathan Stock; Eric Lawrence Bloom; Erin C Durba; Ethan Janus Barlieb; Francis A. DeSimone; Gregory Linkh; Gregory Scott Asciolla; Guylaine Hache; Hannah Schwarzschild; Heidi Marie Silton; Jacob Olawale Onile-Ere; James Arthur Cales , III; James Kevin Fee; Jason Scott Hartley; Jason Z Pesick; Jayne Arnold Goldstein; Jeffrey Robert Moran; Jennifer Kirsten Bracht; Jennifer Laura Greenblatt; Jennifer Lynn Eaton; Jessica Johnston Taticchi; Jessica Noel Servais; John Marcus McNichols; John Paul Bjork; John Peter Coyle; Jon Robert Stickman; Joseph Howard Meltzer; Joseph Michael Vanek; Joseph R Saveri; Joseph Thomas Lukens; Joshua Barton Gray; Joshua Heath Grabar; Justin Boley; Justin Murry Epner; Kara A Elgersma; Karen Hanson Riebel; Karen Sharp Halbert; Karissa Joelle Sauder; Kathleen Ellen Boychuck; Kathryn Jordan Mims; Kenneth Alan Wexler; Kenneth Matthew Holmboe; Kevin Jermone Funk; Kevin Landau; Kip Andrew Harbison; Kristen Anne Johnson; Kyla Gibboney; Lance Victor Oliver; Lauren Carol Ravkind; Lee Albert; Linda Phyllis Nussbaum; Lori Ann Fanning; Marc Christian Greco; Marc Howard Edelson; Marissa Blair Moshell; Mark J. Fanelli; Marvin Alan Miller; Matthew Charles Weiner; Matthew Eric Van Tine; Maureen Smith Lawrence; Melina Rose DiMattio; Micaylee Alexa Noreen; Michael Andrew Glasser; Michael M. Buchman; Michael Minshen Lee; Michelle C Clerkin; Michelle J Looby; Monica Louise Kiley; Natalie Finkelman Bennett; Nicholas Urban; Peter Russell Kohn; Renae Diane Steiner; Richard Alan Arnold; Richard Brendan Fee; Richard Hooper Ottinger; Richard Steven Glasser; Robin Ann van der Meulen; Samantha Maxfield Lerner; Samuel Grant Liversidge; Sarah Elizabeth DeLoach; Scott Eliot Perwin; Sharon Robertson; Stacey Anne Mahoney; Stephanie Smith; Stephen Edward Noona; Steve Shadowen; Steven Andrew Reed; Steven Noel Williams; Susan Rebbeca Podolsky; Tarek Ismail; Terence Scott Ziegler; Teri Josie Diaz; Thomas Matthew Sobol; Timothy Patrick Best; Veronica Smith Lewis; William Hanes Monroe , Jr.; William R. Olson; Wyatt B. Durrette , Jr.; Zachary David Caplan; Zachary Mills Johns | ||
| Firms | Crenshaw Ware & Martin PLC; Duncan & Allen; Durrette, Arkema, Gerson & Gill PC; DurretteCrump PLC; Furniss Davis Rashkind & Saunders PC; Glasser & Glasser Plc; Kaufman & Canoles, P.C.; Law Office of Craig C. Reilly; Morgan Lewis Bockius LLP (DC); Roberts Law Firm, P.A; Straus & Boies LLP (FFX); The Law Offices of Susan R Podolsky; Vandeventer Black LLP (Norfolk); Ventker, Henderson, PLLC; White & Case; Williams & Connolly (Dc); Wilson Sonsini Goodrich & Rosati PC (DC) | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in In Re: Zetia (Ezetimibe) Antitrust Litigation
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Biologic Drugs cited in In Re: Zetia (Ezetimibe) Antitrust Litigation
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for In Re: Zetia (Ezetimibe) Antitrust Litigation (E.D. Va. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-09-11 | 1113 | claimed three patents associated with Zetia, Patent Nos. 5,846,966, RE7721 and 7,030,106, and Glenmark… for all three patents.17 Merck sued Glenmark for infringement of the RE7721 patent on March 23, 2007.18…has received final approval from the FDA.9 Patents and several types of exclusivities may prevent …prevent final approval of an ANDA.10 Where patents or other exclusivity barriers are in place, but the FDA…final approval will not be granted until the patent or exclusivity issues have been resolved.12 One | External link to document | |
| 2018-09-05 | 128 | Amended Complaint | as U.S. Patent No. 7,030,106. The ’106 patent was Merck’s first sterol non-absorption patent. It has…azetidinone patents include the ’365 patent, the ’115 patent, the ’966 patent, the RE’721 patent, and the…three patents for these discoveries (one reissued as U.S. Patent No. RE37,721 (the “RE’721 patent”)).… 5. Patents are not bulletproof. 43. Patents are not bulletproof. Patents are routinely… A patent is also invalid or unenforceable when a later acquired patent is not patentably distinct | External link to document |
| 2018-09-13 | 130 | Amended Complaint | as U.S. Patent No. 7,030,106. The ’106 patent was Merck’s first sterol non-absorption patent. It has…azetidinone patents include the ’365 patent, the ’115 patent, the ’966 patent, the RE’721 patent, and the… Patents are not bulletproof. 48. Patents are not bulletproof. Patents are routinely… A patent is also invalid or unenforceable when a later acquired patent is not patentably distinct…azetidinone patent application – issued as U.S. Patent No. 5,631,365. The ’365 patent was the first-issued | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
